Stock Market Update - May 19, 2026
Today's stock market saw some significant movers. Here's a breakdown of 5 stocks that caught our attention:
1. INM - InMed Pharmaceuticals Inc.
Price: $1.6 | Change: +135.05% ($0.9193)
INM investors cheered a 135.05% gain after InMed Pharmaceuticals Inc. announced a definitive all-stock merger agreement with Mentari Therapeutics Inc. This strategic move, announced on May 19, 2026, will create a new Nasdaq-listed entity, operating under the name Mentari Therapeutics, specifically focused on advancing therapies for migraine prevention.
The combined company, Mentari Therapeutics, will focus on advancing a pipeline of injectable migraine therapies, with regulatory filings for key products anticipated soon. What's particularly noteworthy is the substantial financial backing: a concurrent private placement is expected to raise around $290 million, projected to fund the company's operations through 2028. This merger represents a pivotal strategic shift for InMed, which had previously faced financial challenges, effectively giving it a new direction and robust funding.
2. AMPGZ - Amplitech Group, Inc. Series B Right
Price: $0.58 | Change: +132.00% ($0.33)
AMPGZ has been a standout, soaring by an impressive 132.00%! This surge followed the company's strong first-quarter 2026 financial results, which significantly surpassed analyst expectations. Amplitech Group reported a substantial 48.6% year-over-year jump in revenue, reaching $5.35 million. Even more notable, gross profit more than doubled, increasing by 116.1%, and its gross margin expanded significantly, signaling improved operational efficiency. The company also managed to reduce its net loss.
What makes this movement particularly interesting is not just the past performance but also the future outlook. Amplitech Group strengthened its financial position with $18.4 million in cash and remains debt-free, having successfully raised over $16 million to fuel growth. The company is making strides in commercializing its 5G O-RAN radio systems and MMIC technologies, with shipments resuming under a previously announced $40 million Letter of Intent and an order backlog now exceeding $20 million, pointing to a potentially stronger second half of 2026.
3. AMST - Amesite Inc.
Price: $1.73 | Change: +120.07% ($0.9439)
AMST saw a remarkable 120.07% gain, largely fueled by a significant enterprise customer win announced around May 20, 2026. Amesite Inc. revealed that a major home care provider, serving approximately 2,700 patients, will adopt its NurseMagic™ AI platform. This deal validates the platform's ability to scale and streamline critical tasks like electronic medical records (EMR) and visit verification, potentially saving caregivers up to 16 hours per week on documentation.
Beyond this major contract, market sentiment was boosted by Amesite's ongoing efforts to reduce operating costs—reporting an 18% cut over the past six quarters—and growing demand for its AI solutions. The company also recently secured around $2.6 million in funding, helping it regain compliance with Nasdaq's minimum equity requirements and easing previous liquidity concerns, all contributing to the recent positive movement.
4. CNEY - CN Energy Group. Inc.
Price: $1.61 | Change: +119.77% ($0.8774)
CNEY — While some reports might suggest an eye-popping 119.77% gain for CN Energy Group Inc. (CNEY:NASDAQ) around May 20, 2026, a closer look at market data tells a different story.
Far from surging, the stock was actually experiencing a period of decline during mid-May 2026. For instance, CNEY saw drops of 2.82% and 3.31% on May 15 and May 18 respectively, continuing a downward trend. Analyst outlooks around this time were notably cautious, with some experts even recommending a "Sell."
Although CNEY had some positive developments earlier in 2026, like regaining Nasdaq compliance in March and announcing an acquisition in February, these events occurred months prior and did not correlate with any significant surge near May 20. This serves as a reminder to always verify reported stock movements with actual market data and company news.
5. AMPGR - Amplitech Group, Inc. Series A Right
Price: $0.5 | Change: +102.02% ($0.2525)
AMPGR recently saw an impressive surge of 102.02%. This significant movement came after Amplitech Group, Inc. announced strong first-quarter 2026 financial results on May 13, 2026. The report highlighted substantial year-over-year growth, with revenue increasing by 48.6% to $5.35 million, and gross profit surging by 116.1%. The company also managed to reduce its net loss by 17.3%.
Further bolstering investor confidence, Amplitech improved its cash position to $18.4 million and remains notably debt-free. The company also raised over $16 million in proceeds during the quarter to support growth initiatives. Management reaffirmed its full-year revenue guidance, with expectations to resume shipments on a $40 million Letter of Intent with a major North American mobile network operator, providing a clear path for future revenue.
This analysis was generated using AI and real-time stock data. Always do your own research before making investment decisions.